Middelkoop Keren, Micklesfield Lisa, Hemmings Stephanie, Walker Neil, Stewart Justine, Jolliffe David A, Mendham Amy E, Tang Jonathan C Y, Cooper Cyrus, Harvey Nicholas C, Wilkinson Robert J, Martineau Adrian R
Desmond Tutu HIV Centre, Institute of Infectious Diseases & Molecular Medicine, University of Cape Town, Observatory, South Africa.
Department of Medicine, University of Cape Town, Observatory, South Africa.
BMJ Open Sport Exerc Med. 2024 Sep 26;10(3):e002019. doi: 10.1136/bmjsem-2024-002019. eCollection 2024.
To determine whether vitamin D supplementation influences grip strength, explosive leg power, cardiorespiratory fitness and risk of exercise-induced bronchoconstriction (EIB) in South African schoolchildren.
Substudy (n=450) in Cape Town schoolchildren aged 8-11 years nested within a phase 3 randomised placebo-controlled trial (ViDiKids). The intervention was weekly oral doses of 10 000 IU vitamin D (n=228) or placebo (n=222) for 3 years. Outcome measures were serum 25-hydroxyvitamin D (25(OH)D) concentrations, grip strength, standing long jump distance, peak oxygen uptake (VO, determined using 20 m multistage shuttle run tests) and the proportion of children with EIB, measured at end-study.
64.7% of participants had serum 25(OH)Dconcentrations <75 nmol/L at baseline. At 3-year follow-up, children randomised to vitamin D versus placebo had higher mean serum 25(OH)D concentrations (97.6 vs 58.8 nmol/L, respectively; adjusted mean difference 39.9 nmol/L, 95% CI 36.1 to 43.6). However, this was not associated with end-study differences in grip strength, standing long jump distance, VO or risk of EIB.
A 3-year course of weekly oral supplementation with 10 000 IU vitamin D elevated serum 25(OH)D concentrations in South African schoolchildren but did not influence muscle strength, exercise capacity or risk of EIB.
确定补充维生素D是否会影响南非学童的握力、腿部爆发力、心肺适能以及运动诱发支气管收缩(EIB)的风险。
在开普敦8至11岁学童中进行的子研究(n = 450),该子研究嵌套于一项3期随机安慰剂对照试验(ViDiKids)中。干预措施为连续3年每周口服10000国际单位维生素D(n = 228)或安慰剂(n = 222)。结局指标包括血清25-羟维生素D(25(OH)D)浓度、握力、立定跳远距离、峰值摄氧量(VO,通过20米多级穿梭跑测试测定)以及EIB患儿的比例,均在研究结束时进行测量。
64.7%的参与者在基线时血清25(OH)D浓度<75 nmol/L。在3年随访时,随机分配至维生素D组与安慰剂组的儿童,其平均血清25(OH)D浓度更高(分别为97.6和58.8 nmol/L;调整后平均差值为39.9 nmol/L,95%置信区间为36.1至43.6)。然而,这与研究结束时握力、立定跳远距离、VO或EIB风险的差异无关。
在南非学童中,为期3年的每周口服10000国际单位维生素D的疗程可提高血清25(OH)D浓度,但不会影响肌肉力量、运动能力或EIB风险。